Mazor Robotics

MeMed Bolsters Leadership Team With Appointment of Ori Hadomi as Chairman and Peter Scheu as President of MeMed US

Retrieved on: 
Monday, November 6, 2023
MA, Abbott, Acquisition, Bernie Sanders' Dank Meme Stash, Mazor Robotics, Alere, Record, Public, Medtronic, Partnership, Management

HAIFA, Israel; BOSTON, MA – 6 November, 2023 – MeMed, a leader in host response technologies, today announces the appointment of Mr. Ori Hadomi as Chairman of the Board of Directors and Mr. Peter Scheu, as President of MeMed US.

Key Points: 
  • HAIFA, Israel; BOSTON, MA – 6 November, 2023 – MeMed, a leader in host response technologies, today announces the appointment of Mr. Ori Hadomi as Chairman of the Board of Directors and Mr. Peter Scheu, as President of MeMed US.
  • Ori Hadomi is a renowned leader in the medical device arena, an accomplished serial entrepreneur and CEO with three decades of healthcare experience.
  • Peter Scheu is a seasoned leader with extensive experience in the healthcare and in-vitro diagnostics space.
  • Before that, he served as President North America Commercial Operations at Alere, a global provider of point-of-care diagnostics, later acquired by Abbott.

Precise Bio Appoints Ori Hadomi as Chairman of the Board of Directors

Retrieved on: 
Monday, September 11, 2023
Mazor Robotics, Hebrew University of Jerusalem, Psychoanalysis, 3D, Ori, Al-Quds, Spine, Australian Securities Exchange, Economics, Regenerative medicine, Chemistry, Development, Medtronic, Patient, Robotics, TASE, Aryeh, Ophthalmology, CFO, R, Partnership, Medtech, BD, Management

MODI'IN, Israel and WINSTON SALEM, N.C., Sept. 11, 2023 /PRNewswire/ -- Precise Bio , a pioneering regenerative medicine company specializing in bio-printed tissues and organs, is pleased to announce the appointment of Ori Hadomi as its new Chairman of the Board of Directors.

Key Points: 
  • MODI'IN, Israel and WINSTON SALEM, N.C., Sept. 11, 2023 /PRNewswire/ -- Precise Bio , a pioneering regenerative medicine company specializing in bio-printed tissues and organs, is pleased to announce the appointment of Ori Hadomi as its new Chairman of the Board of Directors.
  • Mr. Hadomi is also actively engaged, in various capacities, with other prominent medical device companies.
  • "We are delighted to have Ori Hadomi as our newly appointed Chairman," said Aryeh Batt, Co- Founder and CEO of Precise Bio.
  • He also serves as a member of the advisory board and chairman of the board of several global medical device companies.

Promaxo Appoints Chad Zaring, Chief Commercial Officer, and Matt Collins, Vice President of Marketing

Retrieved on: 
Thursday, August 10, 2023
Mazor Robotics, University, Marketing, Chief commercial officer, Merck & Co., Ethicon, Business, MBA, ISRG, Intuitive Surgical, Medtronic, Chad, Merck, Johnson & Johnson, AI, Robotics, Pharmaceutical industry

OAKLAND, Calif., Aug. 10, 2023 (GLOBE NEWSWIRE) -- Promaxo, Inc. (“Promaxo” or the “Company”), a medical imaging, robotics, and AI technology company, announced today that it has expanded its sales and marketing organization with the appointment of Chad Zaring as Chief Commercial Officer and Matt Collins as Vice President of Marketing.

Key Points: 
  • OAKLAND, Calif., Aug. 10, 2023 (GLOBE NEWSWIRE) -- Promaxo, Inc. (“Promaxo” or the “Company”), a medical imaging, robotics, and AI technology company, announced today that it has expanded its sales and marketing organization with the appointment of Chad Zaring as Chief Commercial Officer and Matt Collins as Vice President of Marketing.
  • “We are excited to welcome Chad and Matt to our commercial team, with their skills and experience expected to be immediately accretive, particularly given the continued strong momentum in our operations,” said Dr. Amit Vohra, Founder and CEO of Promaxo.
  • He has led sales and marketing efforts at successful companies including Intuitive Surgical (ISRG) and Mazor Robotics (acquired by Medtronic).
  • In his most recent position as Chief Commercial Officer at Momentis Surgical, he was responsible for the commercial launch of the company’s robotic surgery platform.

ForSight Robotics Expands Leadership Team with Appointment of CFO

Retrieved on: 
Tuesday, July 18, 2023
Other Health, Professional Services, Robotics, Optical, Technology, Medical Devices, Hospitals, Surgery, Biotechnology, Medical Supplies, Practice Management, Finance, Health, Levita, Mazor Robotics, Hungary, Head, Business operations, Spine, Multimedia, Forsight Robotics, Medtronic, Acquisition, Patient, TASE, CFO, FDA, Levinson, Management, 3D printing, Medical device

ForSight Robotics, a pioneer of robotic eye surgery, announced today the appointment of Sharon Levita as Chief Financial Officer (CFO), effective September 1, 2023.

Key Points: 
  • ForSight Robotics, a pioneer of robotic eye surgery, announced today the appointment of Sharon Levita as Chief Financial Officer (CFO), effective September 1, 2023.
  • Levita will lead ForSight Robotics’ strategic and financial operations, focusing on driving business strategies, expanding strategic partnerships, and managing financial and growth objectives.
  • View the full release here: https://www.businesswire.com/news/home/20230718734903/en/
    Sharon Levita appointed ForSight Robotics CFO.
  • We are thrilled to welcome Sharon to our team as we continue advancing in the development of our ORYOM Surgical Robotics Platform.”
    “This is such an exciting time to join ForSight Robotics,” said Sharon Levita.

Medical Robotics Market to Grow Significantly by 2029- Brandessence Market Research

Retrieved on: 
Tuesday, May 30, 2023
Titan, Mazor Robotics, Renishaw plc, Intellectual property, Hansen Medical, Surgeon, Medicine, Prevalence, Aethon, IRobot, McKesson Corporation, Feedback, Intuitive Surgical, OR, Ageing, Cancer, Quality of life, Fatality, Laparoscopy, Research, Negotiation, MEA, Government, Smith & Nephew, Stryker Corporation, Hospital, Traction, Acquisition, Patient, Investment, Others, Risk, Robotics, Machine learning, Porter's five forces analysis, Conditional sentence, Artificial intelligence, Cyberdyne, Medtech, Medical device, Health insurance, Vaccine, 3D printing, Video game

The business intelligence report on Medical Robotics Market by Brandessence Market Research presents a detailed overall of the crucial aspects of this industry.

Key Points: 
  • The business intelligence report on Medical Robotics Market by Brandessence Market Research presents a detailed overall of the crucial aspects of this industry.
  • The Medical Robotics Market is anticipated to grow substantially over the forecast duration of 2022-2029.
  • Competitive Rivalry: The medical robotics market is characterized by intense competition among key players.
  • Market leaders invest significantly in research and development to advance their robotic systems, enhance capabilities, and expand their product portfolios.

Medical Robotics Market to Grow Significantly by 2029- Brandessence Market Research

Retrieved on: 
Tuesday, May 30, 2023
Titan, Mazor Robotics, Renishaw plc, Intellectual property, Hansen Medical, Surgeon, Medicine, Prevalence, Aethon, IRobot, McKesson Corporation, Feedback, Intuitive Surgical, OR, Ageing, Cancer, Quality of life, Fatality, Laparoscopy, Research, Negotiation, MEA, Government, Smith & Nephew, Stryker Corporation, Hospital, Traction, Acquisition, Patient, Investment, Others, Risk, Robotics, Machine learning, Porter's five forces analysis, Conditional sentence, Artificial intelligence, Cyberdyne, Medtech, Medical device, Health insurance, Vaccine, 3D printing, Video game

The business intelligence report on Medical Robotics Market by Brandessence Market Research presents a detailed overall of the crucial aspects of this industry.

Key Points: 
  • The business intelligence report on Medical Robotics Market by Brandessence Market Research presents a detailed overall of the crucial aspects of this industry.
  • The Medical Robotics Market is anticipated to grow substantially over the forecast duration of 2022-2029.
  • Competitive Rivalry: The medical robotics market is characterized by intense competition among key players.
  • Market leaders invest significantly in research and development to advance their robotic systems, enhance capabilities, and expand their product portfolios.

AI-based Surgical Robots Global Market Report 2022: Effective Collaboration Between Healthcare & Robotics Designing Software Companies Boosts Sector - ResearchAndMarkets.com

Retrieved on: 
Thursday, December 29, 2022
Robotics, Health, Technology, Surgery, Software, Artificial Intelligence, Titan, Algorithm, Surgeon, Public health, Robotics, Breast cancer, Conditional sentence, Percussion section, MAKO, Growth, Patient, Mortality, Intuitive Surgical, World Health Organization, AI, Safety, Machine learning, Hospital, General surgery, Mazor Robotics, Statistics, Hysterectomy, Prevalence, USFDA, Patient safety, Intelligence, Medical device

Rising public health awareness and enhanced patient safety and compliance bolster the market growth for AI-based surgical robots market.

Key Points: 
  • Rising public health awareness and enhanced patient safety and compliance bolster the market growth for AI-based surgical robots market.
  • Services are holding the largest share in the product segment for AI-based surgical robots market.
  • The chief contributing factors responsible for its global dominance are effective collaboration between healthcare & robotics designing software companies and rising public health awareness pertaining to benefits associated with AI-based surgical procedures.
  • Companies developing AI-based surgical robots are Accuray Incorporated, Hansen Medical, Intuitive Surgical, Inc., MAKO, Mazor Robotics, Medrobotics Corporation, Medtech Surgical, Stereotaxis, Inc., TransEnterix and Titan Medical, Inc.

$4.7 Billion Worldwide Neurosurgical Robotics Industry to 2028 - Rising Number of Product Developments and Approvals Present Opportunities - ResearchAndMarkets.com

Retrieved on: 
Friday, November 18, 2022
Surgery, Health, Robotics, Other Technology, Technology, FDA, Pressure, Neurosurgery, Anatomy, Surgeon, Johnson & Johnson, Spine, Component, Robotics, ROSA, Growth, Mazor Robotics, COVID-19, Brain, Patient, 3D printing, Dentistry

The global neurosurgical robotics market is expected to grow from US$ 1,691.02 million in 2021 to US$ 4,729.86 million by 2028.

Key Points: 
  • The global neurosurgical robotics market is expected to grow from US$ 1,691.02 million in 2021 to US$ 4,729.86 million by 2028.
  • The growth of the global neurosurgical robotics market is attributed to the rise in the number of neurosurgical procedures and the advantages of neurosurgical robots that encourage key players to develop innovative products.
  • Moreover, owing to the increased advancements in neurosurgery, key players are working to grab a significant share in the neurosurgical robotics market.
  • Hence, the advantages of neurosurgical robots encourage key players to develop innovative products in the global neurosurgical robotics market.

AI-based Surgical Robots Global Market Report 2022: Ukraine-Russia War Impact

Retrieved on: 
Thursday, November 24, 2022
Titan, ENT, Gynaecology, Surgeon, COVID-19, Intuitive Surgical, Elective surgery, Colorectal surgery, Prostate cancer, KD, Academic Medicine (journal), Diagnosis, Digital, Growth, Stryker Corporation, Acquisition, Hospital, Ai, Intelligence, Urology, Touch Surgery, AI, Organization, Mazor Robotics, American Medical Association, Neurology, Medical device, Dentistry, Medical imaging, Medtronic

The AI based surgical robots market is expected to reach $8.81 billion in 2026 at a CAGR of 16.99%.

Key Points: 
  • The AI based surgical robots market is expected to reach $8.81 billion in 2026 at a CAGR of 16.99%.
  • The AI-based surgical robots market consists of sales of AI-based surgical robots and related services by entities (organizations, sole traders, and partnerships) that are surgical robots powered by artificial intelligence which are well-known in the medical field and are frequently used.
  • Therefore, the Increasing adoption of technologically advanced robots by surgeons for various applications is driving the Ai-based surgical robots market.
  • The AI-based surgical robots market research report is one of a series of new reports that provides AI-based surgical robots market statistics, including AI-based surgical robots industry global market size, regional shares, competitors with a AI-based surgical robots market share, detailed AI-based surgical robots market segments, market trends and opportunities, and any further data you may need to thrive in the AI-based surgical robots industry.

ForSight Robotics Raises $55 Million in Series A Round to Develop World's First Fully Robotic Cataract Surgery Procedure

Retrieved on: 
Wednesday, July 20, 2022
Eclipse, Mithril, AI, Group, Surgeon, Development, Environment, Defense, JAMA Ophthalmology, Airport, Goodness, Flex (company), Industry, Adani Group, Real estate, Adani, Mechanics, Solution, Software, Eye, Growth, Cataract, Severe cognitive impairment, Apple, Israel Innovation Authority, Robotics, Machine learning, Renewable energy, GE, Intuitive Surgical, Technology, Tesla, Global Public Health (journal), Patient, Quintet Private Bank, Retina, Nation-building, Health, Glaucoma, CSR, Mazor Robotics, Self-help group (finance), Saṃsāra, Intel, 3D printing, Veterinary medicine, Health insurance, Medical device, Management, Ophthalmology, Resource

YOKNEAM, Israel, July 20, 2022 /PRNewswire/ -- ForSight Robotics, the pioneer in ophthalmic robotic surgery, today announced it completed a $55 million Series A round to advance the world's first surgical platform for fully robotic cataract surgery: ORYOM. ForSight's flagship robotic platform will increase accessibility to ophthalmic surgery procedures worldwide and ultimately, transform the future of eye surgery.

Key Points: 
  • YOKNEAM, Israel, July 20, 2022 /PRNewswire/ -- ForSight Robotics , the pioneer in ophthalmic robotic surgery, today announced it completed a $55 million Series A round to advance the world's first surgical platform for fully robotic cataract surgery: ORYOM .
  • ForSight's flagship robotic platform will increase accessibility to ophthalmic surgery procedures worldwide and ultimately, transform the future of eye surgery.
  • Following an initial $10 million mega-seed round last year, ForSight has advanced its technological capabilities and doubled in size.
  • ForSight's first procedure is cataract surgery, the most common surgical procedure with approximately 28M procedures worldwide per year.